FDA in flux: Highlights from DLA Piper’s 2025 Product Liability Symposium panel

Start
DLA Piper’s 2025 Product Liability Symposium featured a panel discussion on key considerations related to shifting Food and Drug Administration (FDA) regulation….
By: DLA Piper
Previous Story

California Injuries Due to Negligent Security: Who is Liable?